Eton Pharmaceuticals, Inc (ETON) Relaunches IMPAVIDO in U.S.
Eton Pharmaceuticals announced U.S. commercial availability of IMPAVIDO (miltefosine) capsules, adding the drug to its rare disease commercial infrastructure and support program.Material DetailsContext by AI AnalystThis extends Eton’s rare disease portfolio, aligning with its strategy to commercial…